- Home
- Medical
- Clinical Medicine
- Vascular Manifestations of Systemic Autoimmune Diseases
Vascular Manifestations of Systemic Autoimmune Diseases
List Price:
$87.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Ronald A. Asherson, Ricard Cervera, Douglas A. Triplett, Steven B. Abramson
Format:
Paperback
Pages:
624
Publisher:
CRC Press (September 11, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367397616
Weight:
16oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260415045548659-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$87.99
Country of Origin:
United States
Pub Discount:
30
As low as:
$83.59
Publisher Identifier:
P-CRC
Discount Code:
H
Imprint:
CRC Press
Case Pack:
1
Overview
Vascular Manifestations of Systemic Autoimmune presents in one volume the clinical syndromes associated with small and large vessel pathology encountered in the autoimmune connective tissue disorders and includes the pathogenesis, clinical implications, and treatment of these diseases. Now that most individuals survive the onset of acute systemic autoimmune diseases and live for decades more, halting the long-term attack on vasculature is increasingly important. It addresses the most current therapies available for treatment (fibrolytic treatments, prostacycline derivatives, and anti-platelet compounds) and includes a separate chapter devoted to the use of long term anticoagulation and the newer low molecular weight heparins.








